首页> 外文期刊>The journal of immunology >The Zone of Localization of Antibodies. XIII. The in Vivo Localization of Anti-Liver-Blood-Vessel Antibodies in the Rat
【24h】

The Zone of Localization of Antibodies. XIII. The in Vivo Localization of Anti-Liver-Blood-Vessel Antibodies in the Rat

机译:抗体本地化区域。十三。大鼠体内抗肝血管血管抗体的体内定位

获取原文
获取外文期刊封面目录资料

摘要

Antisera were prepared in rabbits by injecting rat liver blood vessels. The localization properties of the antibodies were investigated by following the in vivo disposition of radioactivity from the radioiodinated globulin fractions of the sera. Kidney-, liver-, and lung-localizing antibodies could be demonstrated in the serum.When the radioiodinated antibodies which had localized in liver, kidney and lung were eluted at pH 11 and reinjected into recipient rats, the pattern of localization was determined by the organ from which the material was isolated. The localization favored the organ of initial fixation.Radioiodinated normal serum proteins are likewise fractionated in vivo by the liver, kidney and lung when injected into rats. Here, the eluted radioactivity obtained from the liver, kidney and lung also returned preferentially to the organ of initial localization, but to a lower extent than shown by localizing antisera. This fractionation of normal serum proteins was attributed to the ability of the various organs to fix selectively different proteins.Purification of antibodies in vitro was carried out by adsorbing radioiodinated anti-liver serum with liver blood vessel antigen and then eluting the adsorbed radioactivity at pH 11. These preparations showed increased localization in the liver and kidney while no increased localization was observed in the controls.
机译:通过注射大鼠肝血管在兔体内制备抗血清。通过从血清的放射性碘化球蛋白级分体内放射活性的体内处置来研究抗体的定位特性。可以在血清中证实肾,肝和肺的定位抗体。当已在肝,肾和肺中定位的放射性碘化抗体在pH 11下洗脱并重新注入受体大鼠时,通过从中分离出材料的器官。该定位有利于初始固定的器官。当将放射性碘标记的正常血清蛋白注射入大鼠体内时,其在体内同样被肝,肾和肺分级。在这里,从肝脏,肾脏和肺部获得的洗脱放射性也优先返回到初始定位器官,但程度比通过定位抗血清显示的要低。正常血清蛋白的这种分离归因于各个器官选择性地固定不同蛋白的能力。通过用肝血管抗原吸附放射性碘化的抗肝血清,然后在pH 11下洗脱吸附的放射性来进行抗体的体外纯化。这些制剂显示在肝脏和肾脏中的定位增加,而在对照中未观察到定位增加。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号